BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3166071)

  • 1. Cytogenetic analysis of melanocytes from premalignant nevi and melanomas.
    Cowan JM; Halaban R; Francke U
    J Natl Cancer Inst; 1988 Sep; 80(14):1159-64. PubMed ID: 3166071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible involvement of the chromosome region 10q24----q26 in early stages of melanocytic neoplasia.
    Parmiter AH; Balaban G; Clark WH; Nowell PC
    Cancer Genet Cytogenet; 1988 Feb; 30(2):313-7. PubMed ID: 3422583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic analysis in melanoma and nevi.
    Cowan JM; Francke U
    Cancer Treat Res; 1991; 54():3-16. PubMed ID: 1673858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetics of human malignant melanoma and premalignant lesions.
    Balaban G; Herlyn M; Guerry D; Bartolo R; Koprowski H; Clark WH; Nowell PC
    Cancer Genet Cytogenet; 1984 Apr; 11(4):429-39. PubMed ID: 6584203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth factor and cytogenetic abnormalities in cultured nevi and malignant melanomas.
    Richmond A; Fine R; Murray D; Lawson DH; Priest JH
    J Invest Dermatol; 1986 Mar; 86(3):295-302. PubMed ID: 3745955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of cultured human melanocytes isolated from different stages of tumor progression.
    Herlyn M; Thurin J; Balaban G; Bennicelli JL; Herlyn D; Elder DE; Bondi E; Guerry D; Nowell P; Clark WH
    Cancer Res; 1985 Nov; 45(11 Pt 2):5670-6. PubMed ID: 4053039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor progression in the human melanocytic system.
    Kath R; Rodeck U; Menssen HD; Mancianti ML; Linnenbach AJ; Elder DE; Herlyn M
    Anticancer Res; 1989; 9(4):865-72. PubMed ID: 2554787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysplasia, dysplastic melanocytes, dysplastic nevi, the dysplastic nevus syndrome, and the relation between dysplastic nevi and malignant melanomas.
    Ackerman AB; Mihara I
    Hum Pathol; 1985 Jan; 16(1):87-91. PubMed ID: 3972389
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
    Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
    Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell kinetics of melanocytes in common and dysplastic nevi and in primary and metastatic cutaneous melanoma.
    Urso C; Bondi R; Balzi M; Scubla E; Mauri P; Becciolini A; Tarocchi S; Vallecchi C
    Pathol Res Pract; 1992 Apr; 188(3):323-9. PubMed ID: 1625997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMB-45 staining of dysplastic nevi. Support for a spectrum of progression toward melanoma.
    Smoller BR; McNutt NS; Hsu A
    Am J Surg Pathol; 1989 Aug; 13(8):680-4. PubMed ID: 2473661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype.
    Albino AP; Nanus DM; Mentle IR; Cordon-Cardo C; McNutt NS; Bressler J; Andreeff M
    Oncogene; 1989 Nov; 4(11):1363-74. PubMed ID: 2682463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal changes in dysplastic nevi.
    Marras S; Faa G; Dettori T; Congiu L; Vanni R
    Cancer Genet Cytogenet; 1999 Sep; 113(2):177-9. PubMed ID: 10484987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of proliferative nodules and lethal melanomas in congenital nevi from children.
    Yélamos O; Arva NC; Obregon R; Yazdan P; Wagner A; Guitart J; Gerami P
    Am J Surg Pathol; 2015 Mar; 39(3):405-15. PubMed ID: 25517953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma.
    McNeal AS; Liu K; Nakhate V; Natale CA; Duperret EK; Capell BC; Dentchev T; Berger SL; Herlyn M; Seykora JT; Ridky TW
    Cancer Discov; 2015 Oct; 5(10):1072-85. PubMed ID: 26183406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cells in melanocytic skin lesions. An immunohistochemical and quantitative study.
    Dyduch G; Okoń K; Pescarini E
    Pol J Pathol; 2011 Sep; 62(3):139-44. PubMed ID: 22102069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic Characterization of Dysplastic Nevi Unveils Implications for Diagnosis of Melanoma.
    Melamed RD; Aydin IT; Rajan GS; Phelps R; Silvers DN; Emmett KJ; Brunner G; Rabadan R; Celebi JT
    J Invest Dermatol; 2017 Apr; 137(4):905-909. PubMed ID: 27890785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic characteristics of cells derived from precursors of human melanoma.
    Herlyn M; Herlyn D; Elder DE; Bondi E; LaRossa D; Hamilton R; Sears HF; Balaban G; Guerry D; Clark WH
    Cancer Res; 1983 Nov; 43(11):5502-8. PubMed ID: 6616481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome 7 aneusomy. A marker for metastatic melanoma? Expression of the epidermal growth factor receptor gene and chromosome 7 aneusomy in nevi, primary malignant melanomas and metastases.
    Udart M; Utikal J; Krähn GM; Peter RU
    Neoplasia; 2001; 3(3):245-54. PubMed ID: 11494118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic copy number analysis of a spectrum of blue nevi identifies recurrent aberrations of entire chromosomal arms in melanoma ex blue nevus.
    Chan MP; Andea AA; Harms PW; Durham AB; Patel RM; Wang M; Robichaud P; Fisher GJ; Johnson TM; Fullen DR
    Mod Pathol; 2016 Mar; 29(3):227-39. PubMed ID: 26743478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.